Skip to main content
7-day free trial. Cancel anytime.

Improve Report TAT in Pathology Labs: A Stage-by-Stage Playbook

By Dr.Lably Team · 9 min · Published 2026-02-03 · Updated 2026-07-30

Find and fix the specific stage where your report turnaround time is actually breaking down, with a queue ownership model and a weekly review cadence.

Key takeaways

  • Total TAT hides where the delay actually happens. Measure stage-wise time (accession, processing, validation, approval, release) before trying to fix anything.
  • Most recurring TAT problems are inconsistent decision-making, not slow software — different shifts handling the same exception differently multiplies delay.
  • Give each reporting stage a named owner with a visible target, not just a shared queue everyone is theoretically responsible for.
  • A weekly TAT review by test category, branch, and shift catches process drift while it's still a small problem.

Measure stage-wise time before changing anything

"Our TAT is too slow" isn't specific enough to act on. A report that takes six hours end to end could be losing four of those hours in a validation backlog, or two hours waiting for a single approver who's also doing something else. Map every stage from sample collection to report release, then time each one separately for a representative week.

This single step usually reveals that most labs don't have a uniform TAT problem — they have one or two specific bottleneck stages that account for most of the delay, while the rest of the pipeline is already reasonably fast.

A stage-wise framework to find the actual bottleneck

Use this as a starting structure. Track average time per stage for a week, then compare stages against each other, not against an abstract benchmark — the goal is finding your lab's specific bottleneck.

StageCommon cause of delayWhat usually fixes it
AccessionManual data entry, unclear priority triageBarcode-linked entry, standardized priority rules
Analyzer processingDelayed feeds, reruns not flagged clearlyReal-time exception alerts, a defined rerun protocol
ValidationInconsistent thresholds between shiftsWritten validation rules applied uniformly across shifts
ApprovalSingle approver bottleneck, unclear ownershipNamed owner with a visible target window per shift
Release/deliveryManual report handoff or printingAutomated digital delivery on approval

Standardize decisions so TAT doesn't depend on who's on shift

A large share of avoidable delay comes from teams re-deciding the same situations differently each time: how to prioritize a rush sample, when a result needs a rerun, what counts as a critical value requiring immediate escalation. Write these rules down once, apply them across every shift, and TAT variance drops even before you touch any technology.

  • A written priority protocol for STAT/urgent samples that every shift follows identically
  • Clear validation thresholds so borderline results aren't re-judged case by case
  • A defined exception path for delayed analyzer feeds and reruns that doesn't block the rest of the queue
  • An explicit critical-value escalation chain, so nobody has to decide who to call in the moment

Give every queue an owner and a visible target

TAT improves reliably when accession, validation, approval, and release each have a named owner with a stated target window — not a shared queue that's everyone's responsibility and therefore nobody's. Live dashboard visibility into pending and delayed samples lets that owner intervene before a small delay becomes an end-of-day backlog.

Run a weekly review, not a quarterly one

Review TAT by test category, branch, and shift every week, not once a quarter. Weekly cadence catches drift — a specific shift, test type, or branch quietly slipping — while it's still a small, fixable gap. Document each corrective action with an owner and a deadline, then check the following week whether it actually moved the number. Consistency in this review habit outperforms any single one-time optimization project.

Frequently asked questions

What's a reasonable first step to reduce pathology report TAT?

Measure stage-wise time for one representative week before changing any process. Most labs assume TAT is a general speed problem when it's actually one specific bottleneck stage — you can't fix what you haven't isolated.

How often should TAT be reviewed?

Weekly, broken down by test category, branch, and shift. Quarterly reviews catch problems only after they've compounded into a larger operational issue.

Does better software alone fix TAT problems?

Rarely on its own. Automation helps once the underlying process is defined — standardized priority rules, validation thresholds, and clear queue ownership — but automating an inconsistent process just makes the inconsistency faster.

Next step for your lab

Want to apply this to your workflow? Book a personalized demo.